Previous Article | Next Article 
Journal of Clinical Microbiology, August 2000, p. 3029-3035, Vol. 38, No. 8
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Genetic Diversity, Distribution, and Serological
Features of Hantavirus Infection in Five Countries in South
America
P. J.
Padula,1,*
S. B.
Colavecchia,1
V. P.
Martínez,1
M. O.
Gonzalez Della Valle,1
A.
Edelstein,1
S. D. L.
Miguel,1
J.
Russi,2
J. Mora
Riquelme,3
N.
Colucci,4
M.
Almirón,5 and
R. D.
Rabinovich1
Departamento de Virología, Instituto
Nacional de Enfermedades Infecciosas, A.N.L.I.S. "Dr. Carlos G. Malbrán," 1281 Buenos Aires, Argentina1;
Departamento de Laboratorios, Ministerio de Salud
Pública, 11600 Montevideo, Uruguay2;
Seccion Virología, Instituto de Salud Pública,
Ministerio de Salud Pública de Chile, Casilla 48, Santiago,
Chile3; Laboratorio Central de Salud
Pública, Ministerio de Salud Pública y Bienestar
Social, Asunción, Paraguay4; and
Instituto de Investigaciones en Ciencias de la Salud,
Universidad Nacional de Asunción, Río de la Plata y
Lagerenza, Asunción, Paraguay5
Received 13 January 2000/Returned for modification 5 April
2000/Accepted 30 May 2000
 |
ABSTRACT |
Since 1995 when the first case of hantavirus pulmonary syndrome
(HPS) was reported in Patagonia, there have been more than 400 cases of
HPS reported in five countries in South America. The first case of HPS
was associated with Andes (AND) virus. In this study, we report on the
genetic diversity, geographical distribution, and serological features
of hantavirus infection in six countries in South America based on 87 HPS cases from Argentina, Bolivia, Chile, Paraguay, and Uruguay. An
early immunoglobulin M (IgM), IgA, and IgG humoral response was
observed in almost all HPS cases. The IgM response appears to peak 1 or
2 days after the onset of symptoms. Peak IgG antibody titers occur
mostly after the first week. Low IgG titers or the absence of IgG was
associated with higher mortality rates. The IgA response peaks around
day 15 and then rapidly decreases. The results of phylogenetic analysis
based on partial M-fragment G1- and G2-encoding sequences showed that HPS cases from the five countries were infected with viruses related to
AND or Laguna Negra (LN) virus. Within AND virus-infected persons, at
least five major genetic lineages were found; one lineage was detected
in Uruguayan and Argentinean cases from both sides of the Rio de la
Plata river. Two Paraguayan patients were infected with a virus
different from LN virus. According to the results of phylogenetic
analyses, this virus probably belongs to a distinct lineage related
more closely to the AND virus than to the LN virus, suggesting that
there is probably an Oligoryzomys-borne viral variant
circulating in Paraguay. These studies may contribute to a better
understanding of hantavirus human infection in South America.
 |
INTRODUCTION |
The hantaviruses (family
Bunyaviridae) are enveloped viruses with a tripartite
negative-sense RNA genome. The three genomic segments S, M, and L code
for a nucleocapsid protein (N), two envelope glycoproteins (G1 and G2),
and a viral transcriptase, respectively (5, 23). Several
members of the genus Hantavirus including Seoul (SEO),
Hantaan (HTN), Dobrava (DOB) carried by Murinae rodents, and Puumala
(PUU) carried by an Arvicolinae rodent are associated with hemorrhagic
fever with renal syndrome (HFRS) (11). In 1993, a new
illness associated with sigmodontine-borne hantaviruses, hantavirus
pulmonary syndrome (HPS), in North America was described (4, 9,
10). The causative agent was Sin Nombre (SN) virus
(18), which is responsible for most of the HPS cases in
North America; however, many other HPS-associated viruses have been
discovered in recent years.
Since 1995 when the first HPS case in Patagonia was associated with
Andes virus (AND) (13), more than 400 HPS cases have been
reported in six countries of South America: Argentina, Bolivia, Brazil,
Chile, Paraguay, and Uruguay. The mortality rate was high, ranging from
70% for the first cases to 30% for more recent outbreaks.
Several differences between South and North American hantavirus
infection were observed. High seroprevalence levels in Indian populations inhabiting Paraguayan and Argentinean sectors of the Gran
Chaco were observed (7, 30). Person-to-person transmission has been demonstrated for Andes (AND) virus in Argentina
(19) and are likely for the two family clusters in Chile
(27). Also, cases in South America differed in some clinical
characteristics: renal insufficiency and elevated creatinine kinase
levels were observed at much higher frequency, and proteinuria,
myositis, and conjunctival injection showed more severe manifestations
(25).
In phylogenetic analysis, all sigmodontine hantaviruses from six
countries in South America clustered together and in a different group
from that of North American viruses (8, 12, 13, 20). Although several viral lineages carried by different rodent species have been reported, an exhaustive study of genotypes associated with
human infection according to geographical localization has not been
done. The relationship between phenotype and clinical manifestation has
not been elucidated. The kinetics of the immune response and
serological prognostic markers of different stages of infection have
not been determined.
To determine the genotypes and distribution of hantavirus causing
HPS in five countries in South America, we conducted a nucleotide sequence analysis of HPS-associated viruses from the region. In addition, we studied the serological response and its relationship with
the stage of disease in these patients and the probability of dying
from the infection.
 |
MATERIALS AND METHODS |
Study population.
Routine serum samples from suspected HPS
cases from Argentina, Chile, Paraguay, and Uruguay were collected
during a 4-year period. Eighty-seven patients were confirmed as having
hantavirus by serology. A total of 147 acute, early convalescent, and
late-convalescent phase (3 to 13 months) sera were available from these
patients. The study included 70 males and 17 females aged 3 to 65 years. Clinical and pathologic findings could distinguish two illness severities: 52 severe HPS cases, 48 of which required mechanical ventilation, and 29 mild cases with lower respiratory compromise associated with myalgia, fever, and headache. Clinical data from six
cases were not available.
Serology.
For detection of AND virus-specific immunoglobulin
G (IgG) and IgA antibodies, enzyme-linked immunosorbent assay (ELISA)
was performed on serum samples as previously described (20).
Briefly, patient and control sera were diluted 1:100 and fourfold up to 1:6,400. A recombinant AND nucleoprotein (N) was used as a specific antigen. For IgM detection, a µ-capture ELISA was performed using the
same recombinant antigen and rabbit hyperimmune serum as a second
antibody. Signal reaction was detected using
2,2'-azinobis(3-ethylbenzthiazolinesulfonic acid) (ABTS) as a substrate
for peroxidase. Sera with an optical density of >0.3 were considered
positive. All commercial reagents were from Kirkegaard and Perry.
Statistical analysis.
Antibody responses between surviving
and nonsurviving patients were tested for differences by Student's
t test (two tailed). Differences were considered significant
at P of <0.05. EpiInfo version 6.04 (Centers for Disease
Control and Prevention, Atlanta, Ga.) was used to calculate
t test and odds ratios.
RNA extraction, reverse transcription-polymerase chain reaction
(RT-PCR), and sequencing.
Total RNA was extracted from blood
samples, clots, sera, or organs of HPS patients using the guanidinium
isothiocyanate-acid phenol extraction procedure as described previously
(13). For RNA purification, the RNaid kit (Bio101) was
utilized following the manufacturer's recommendations.
Partial S and M segments were amplified by RT-PCR followed by a second
round of nested or heminested PCR. Specific oligonucleotide primers
based on conserved regions of AND virus genome were used. Sequences and
positions of the primers have been described elsewhere (19,
20). Positions of the S and M segments fragments were numbered
relative to those of AND and SN viruses, respectively. Amplification
products were separated on agarose gels, gel purified, and manually
sequenced by the dideoxy cycle sequencing technique (fmol DNA
Sequencing System; Promega) or by the fluorescent sequencing technique
(dRhodamine Terminator Cycle Sequencing kit; Applied Biosystem) using
an ABI 377 automatic sequencer.
Phylogenetic and comparative sequence analyses.
Multiple-sequence alignment and comparison of nucleotide and deduced
amino acid sequences were performed using CLUSTAL V, a PCGENE 6.8 software program of Intelligenetics Inc. (Mountain View, Calif.).
Maximum-parsimony (MP) and neighbor-joining analyses of nucleotide and
putative amino acid sequence viruses were performed
using the PHYLIP
(Phylogeny Inference Package), version 3.57c.
(J. Felsenstein,
University of Washington, Seattle, Wash.). DNAPARS
and PROTPARS
programs were used to obtain MP trees for nucleotide
and protein
sequences, respectively. The lengths of the tree stems
are proportional
to genetic distances obtained using the DNADIST
program for nucleotide
analyses, weighing transversion twice as
transitions; meanwhile for
protein sequences, distances were obtained
using the PROTDIST
program with the Dayhoff substitution matrix.
The FITCH program was
used to fit distances to MP
trees.
The following published M-segment sequences were included in the
analysis: New York (NY) virus Rhode Island-1,
U36801;
Sin Nombre (SN)
virus,
L25783; Lechiguanas (LEC) virus strain,
Af028022; Laguna Negra
(LN) virus, Af005728; Bayou (BAY) virus,
L36930; Black Creek Canal
(BCC) virus,
L39950; Puumala (PUU)
virus Sotkamo strain,
X61034;
Prospect Hill (PH) virus,
X55129;
Seoul (SEO) virus,
M34882; and
Hantaan (HTN) virus,
M14627.
 |
RESULTS |
Serological response.
A total of 147 blood or serum samples
were collected from 87 patients and tested for antibodies and/or viral
genome to establish the viral genome and serological reactivity for
immunoglobulins to AND virus nucleoprotein after hantavirus infection.
The IgM, IgG, and IgA responses in HPS patients over time is presented
in Fig.
1. The IgM response appears to
peak 1 or 2
days after the onset of symptoms and is detected in serum
for
up to 2 months. Mean IgG antibody titers peak slightly later than
the mean for IgM, mostly after the first week and reach the maximum
optical density levels around day 17. Thirty days after the onset
of
symptoms, IgG exceeds 25,600 reciprocal end titers in most
of the
cases. No significant decrease in IgG antibody titers was
observed
during the 13-month study period. The first samples available
from
almost all patients were positive for IgM. The exception
was two acute
cases in Northern Argentina; for a few days, IgM
could not be detected,
although RT-PCR and IgG were positive.
The IgA response was similar to
the IgM response, reaching high
levels around day 15. However, in some
patients, the IgA curve
showed a more pronounced decline than the IgM
curve. Considering
this finding, high levels of serum-specific IgA
could be highly
indicative of an acute infection.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Andes virus-specific IgG, IgA, and IgM antibody
responses in 147 HPS acute or recent convalescent serum samples. Assay
results on sera collected from one individual at different times are
shown connected by a line. Each point represents the median daily value
for the data group studied. O.D., optical density.
|
|
In a comparison of patients who died and those who survived, we
observed lower IgG antibody values against AND N protein in
the
patients who died than in those who survived (Fig.
2) in both
children and adult patients.
Using Student's
t test, significant
differences in IgG
values between survivors and nonsurvivors were
obtained in intervals of
3 to 4, 5 to 6, and 10 to 13 days after
onset of symptoms. In order to
analyze the usefulness of specific
IgG data for predicting whether
patients survived, the odds ratio
for a value below the median antibody
response for all patients
was calculated using the first sample
available. For the 91 patients,
the odds ratio (95% confidence
interval) obtained was 6.45 (2.14
to 20.14) (
P = 0.0003).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
IgG responses in surviving ( ) and nonsurviving ( )
patients with acute infections of AND virus. Time (in days after onset
of symptoms) is shown on the x axis, and optical density
(1:400) is shown on the y axis. The data for five children
less than 13 years old who died and six children less than 13 years who
survived are included here. The solid line represents the mean IgG
values for survivors; the dotted line represents the mean IgG values
for nonsurvivors (each point [ ] is the average IgG value for a
consecutive 2-day interval).
|
|
Either M- or S-fragment segments were detected by RT-PCR in 81 of 87 samples from patients with acute infection between 1
to 30 days after
the onset of symptoms. For HPS contact studies,
we collected samples
prior to the onset of symptoms. The viral
genome could be detected
using RT-PCR in a sample obtained 7 days
before the onset of symptoms;
however, no viral genome was amplified
between days 10 to 26 prior to
the
illness.
Phylogenetic analyses and geographic distribution.
In order to
determine which hantavirus lineage is associated with human infections
in five countries in South America (Argentina, Bolivia, Chile,
Paraguay, and Uruguay), a MP phylogenetic analysis based on nucleotide
differences in M-segment PCR fragments of the G1-coding region
(positions 88 to 281 and 1736 to 1987) and a fragment of the G2-coding
region (positions 2721 to 2946) of the cases we studied and other
hantaviruses was performed (Fig. 3). All
the cases we studied were related to AND or Laguna Negra (LN) virus
variants (Fig. 3A). There are at least five different genetic lineages
within AND virus (strongly supported by high bootstrap values) from
human cases. The AND Sout lineage was characterized from South
Argentinean and Chilean patients. These sequences clustered together with the Epilink/96 sequence, which was associated with 16 cases of person-to-person transmission (19). The AND Nort lineage was observed in North Argentine provinces (Jujuy and Salta), including the previously reported Oran genotype (12). In the central region of Argentina, two different lineages were found. The AND
Cent Bs.As. lineage includes the Hu39694 genotype previously reported. The AND Cent Lec lineage clustered with the Lechiguanas (LEC) genotype described previously (12). The AND Cent BsAs lineage was detected in several locations of Buenos Aires province, and
the AND Cent Lec lineage was detected near the river regions. A new
lineage named AND Cent Plata was characterized from cases from both
sides of the Rio de la Plata river (Argentina and Uruguay). The AND
Cent Bs.As. lineage was more prevalent near the central Argentine
region, where it accounts for 80% of infections. Nucleotide and amino
acid identities among AND lineages ranged from 76.5 to 86.6% and 91.9 to 96.9%, respectively (Table 1).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Phylogenetic relationship of hantaviruses based on
nucleotide and amino acid sequences of three M-segment PCR fragments
(nt 88 to 281 and 1736 to 1987 of G1 and nt 2721 to 2946 of G2). The
lengths of the lines are proportional to genetic distances. The values
next to the branches indicate the bootstrapping confidence limits (as
percentages) from 500 replicates. (A) Nucleotide sequences were
analyzed by the MP method (DNAPARS) using the PHYLIP package. Viral
sequences geographically related to representative cases for each
lineage are shown within the dotted lines. (B) Putative amino acid
sequences were analyzed by the MP method (PROTPARS) using the PHYLIP
package. The map shows the geographic distribution of the different
virus lineages related to HPS cases. Sequences shown in roman type (not
bold) were obtained from GeneBank.
|
|
From the six viruses characterized from Paraguayan patients, four
viruses were characterized as LN. The other two patients
were infected
with very similar viruses, although around 25% nucleotide
and 16%
amino acid divergences were found when these viruses were
compared to
LN virus for the 672-nucleotide (nt) sequence analyzed.
When comparing
with the AND virus lineages, nucleotide and amino
acid identities
ranged from 78.6 to 80.6% and 93.2 to 95.0%, respectively.
These
sequences clustered with the AND virus in parsimony phylogenetic
analysis supported by a high bootstrap value (94%). The Arg-Bol/98
virus belongs to an Argentinean patient who worked in Bolivia
but was
hospitalized in North Argentina near the border with Bolivia.
This
sequence clustered with the LN
virus.
The topology of the tree based on the amino acid sequence obtained
using MP analysis (Fig.
3B) is very similar to the one
obtained using
nucleotide sequence. However, in the amino acid
analysis, the distances
within the AND virus cluster are much
smaller than those obtained for
other clusters. Phylogenetic analysis
performed using the
neighbor-joining method produced a tree (not
shown) very similar to the
tree obtained using the MP
method.
Severe and moderate cases were found among persons infected with any of
the five AND virus lineages. There have been some
reported cases of
clear hemorrhagic signs associated with infection
with viruses
belonging to the AND Sout, AND Nort, and AND Cent
Bs.As.
lineages.
Lineages and genetic variations of HPS hantaviruses.
Several
regions of the AND virus genome have been analyzed with the purpose of
furthering genotypic classification. The G2-encoding protein sequence
(positions 2721 to 2946) of 70 viruses and the N conserved region of
the S segment (nt 69 to 219) of 32 viruses have been amplified,
subjectly to sequence analysis, and studied for that purpose. After
alignment, the percentages of similarities were calculated. A frequency
distribution of similarity percentages obtained from the G2 fragment
region indicates that similarities segregate mainly into three ranges.
Similarities were high (90 to 100%) between viruses of the same
lineage. Similarities were intermediate (74 to 86%) between viruses of
different lineages or different viruses characterized from the five
countries in South America studied (e.g., LN and AND). Similarities
were low (63 to 78%) for two viruses from different hemispheres or
between different North American viruses (e.g., AND Sout and SN or BY and NY) (Fig. 4). Similarities for the N
conserved region of 151 bp from viruses of the same or different
lineages more frequently overlap each other (data not shown).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Sequence comparisons of the different Andes lineages and
American HPS hantaviruses. The frequency (F) versus the percentage of
similarity (S) from a total of 76 samples obtained after comparison of
5,700 paired sequences of a 226-nt G2 fragment (nt 2721 to 2946).
Striped bars represent different sequences belonging to the same AND
lineage. White bars represent sequences belonging to different AND
lineages or viruses from the six countries in South America studied.
Black bars represent North American HPS viruses, American viruses, or
viruses from different hemispheres. The AND lineages include 14 AND
Nort samples, 16 AND Cent Bs.As. samples, 5 AND Cent Plata sequences, 3 AND Cent Lec sequences, and 29 AND Sout sequences. North American HPS
viruses include SN, NY, BCC, and BAY. South American HPS viruses
include LN, Parag3/98, Parag1/98, and Arg-Bol/98. MACIEL virus was also
included in the analysis.
|
|
Incubation period of Andes virus.
The occurrence of interhuman
transmission makes follow up of HPS contacts crucial. The available
estimation of the incubation period was 4 to 42 days for HFRS
(11) and 2 to 3 weeks for SN virus infection
(10).
In order to estimate the incubation period for AND virus infection in
person-to-person transmission, we performed a combinatory
approach to
find a mean and standard deviation, assuming that
the incubation period
follows a normal distribution. The best-known
epidemiological cases
with the following restrictions were considered.
(i) Each case B was in
contact between days 4 to 50 before onset
of symptoms with only one
previous HPS case named A. (ii) Viral
nucleotide sequences found in
both cases must be identical (at
least in 1,000 bp of the S and/or M
segment). (iii) No exposure
to rodents should be recorded for case B
during the 50 days before
the onset of the symptoms. Six cases with
these restrictions were
available. The actual intervals between the
onset of A and B symptoms
in the six cases considered were 16, 18, 19, 21, 25, and 29
days.
The following three assumptions were used. (i) The infectivity
inf
Aj, defined as the conditional probability of the
infection
due to contact between HPS case A and a noninfected person on
day j, follows a normal distribution with a maximum value at the
day of
the onset of symptoms in case A and a standard deviation
equal to 2 days. (ii) Only one infection event was considered.
(iii) The
incubation period of case B follows a normal distribution
with mean
X and standard deviation
s, both to be estimated.
The
probability of case B (
pBj) acquiring the
infection on day j was
calculated using
X and
s.
The relative probability (
IABj) of case B being
infected by case A on day j is given by
IABj = inf
Aj
pBj cABj, where
C
ABj is zero if A and B have not been in contact and one if
there was
contact between A and B. In order to find the
X
and

pair that
gives the best fit with our data, we defined the
function

as

,
where
j varies between

4 and

50 days. Day zero corresponds to
the onset of symptoms in case B.

resembles a probability function
taking all the cases into account.

values were calculated using
all
combinations of
X and

(
X varying between 4 and 50 and
varying between 0 and 15, using a 0.2 step). The maximum
value
of

was obtained with
X = 19.2 and
s = 5.2.
On the basis of the limited data and the assumptions mentioned above,
the incubation period for 85% of the cases would be
days 12 to 27. These values could be used as estimates for the
periods that the HPS
case contacts should be followed
up.
 |
DISCUSSION |
We consider clinical, immunological, and virological data from 87 HPS cases from five countries of South America: Argentina, the country
with the highest number of reported HPS cases, Bolivia, Chile,
Paraguay, and Uruguay (which had 233, 397, 41, and 16 total cases,
including those from 1999, respectively). The clinical presentation of
HPS cases varied from moderate to severe. Multiple factors could be
associated with different mortality rates in each region including
variation in medical therapies, difference in pathogenesis of local
virus, or HLA haplotype prevalence. Clinical and laboratory findings
were similar in all regions studied, including patients with renal
compromise or hemorrhagic signs. However, human-to-human transmission
was reported only in South Argentina and Chile (6, 19, 27,
29). The decrease of mortality in recent years may be related to
the improvement of diagnostic methods and medical treatments, but any
association between the mortality rate or severity of infection with a
particular lineage cannot be determined yet. The presence of two or
more hantaviruses in a region is another factor to be considered in
mortality rate analyses.
An early and strong IgM, IgA, and IgG humoral response was observed in
almost all HPS cases. Low IgG titers or the absence of IgG has been
associated with a higher mortality rate and leads to the question of
the involvement of IgG antibodies in protection, although it should be
noted that N protein does not stimulate a neutralizing antibody
response. In a previous report, three Argentinean children with no
detectable IgG response to SN virus antigens died (22). From
a clinical perspective, a median as cutoff point seems to be an
arbitrary value; however, on the basis of these results, we found that
patients with higher IgG-specific response have a low probability of
dying from the infection. A lower IgG response combined with other
markers may be useful in identifying patients with higher mortality
risk. Determination of the incubation period could be useful to
establish the place where a traveler may have been infected and to
analyze the transmission chain in complex situations. For this
determination, we consider the highest infectivity to be near the onset
of symptoms based on observations of AND interhuman transmission. For
SN infection, a recent report showed a high level of viremia present on
the day edema occurred, followed by a rapid decrease (26).
Knowledge of the period of incubation and prognosis markers can
contribute to the follow up of the contacts and treatment of the patients.
The IgA response reaches high levels in patient sera around day 15 and
rapidly decreases at the end of the acute phase. These antibodies could
be used together with IgM and IgG to improve the diagnostic accuracy of
cases with low IgM response values in order to define the stage of
infection in patients in which the course of infection is atypical. In
addition, detection of IgA in saliva could be an important tool in
populations where it is not possible to obtain blood by venipuncture
due to cultural reasons (20). Lack of detection of IgM
antibodies in sera from the two patients reported here could be caused
by a reinfection event. However, for hantaviruses, reinfection has not
been described. ELISA was performed three times in the unique sample
from each case available with identical results (2 and 4 days after
onset of symptoms).
Viral RNA is regularly detected in patients with acute infections. The
presence of virus and our ability to detect viral genome in HPS contact
patients by RT-PCR at least 7 days prior to the onset of symptoms
showed that this test could be useful in deciding early antiviral therapies.
For a better understanding of the variability of these viruses in South
America, partial M and S segments were analyzed. Phylogenetic analysis
based on partial M-fragment G1- and G2-encoding sequences showed that
HPS cases from Argentina, Chile, Paraguay, and Uruguay were infected
with AND or LN viruses. Within AND virus-infected persons, at least
five major lineages were found, two present in distant geographical
regions and three in contiguous regions. Variants from Patagonia,
southern Argentina, and Chile named AND Sout, clustered with the first
virus characterized for the region (13). This lineage
included sequences related with person-to-person transmission. A new
lineage was found in HPS cases from both sides of the Rio de la Plata
river (AND Cent Plata). It was shown in Oligoryzomys studies
that passive transport of animals would promote unidirectional gene
flow along the river and lack of isolation by distance (3).
In one locality of Buenos Aires province, two viral lineages, AND Cent
Plata and AND Cent Bs.As., were associated with HPS cases. We found a
maximum nucleotide divergence of 23.5% between AND Sout and AND Cent
Bs.As. and a minimum value of 13.4% between AND Cent Plata and AND
Cent Lec. However, in all comparisons, amino acid divergence is between
3 to 8%. Neither the genotypes Pergamino and Maciel characterized
previously in the central Argentine region from Akodon
azarae and Necromys obscurus (ex Bolomys), respectively, nor the Bermejo genotype from Oligoryzomys
chacoensis in North Argentina reported (12) was found
in human cases. However, the fact that Pergamino and Maciel genotypes
have not been demonstrated in human cases may just mean that rodent
species reservoirs have not undergone a population explosion.
Two Paraguayan patients were infected with a virus different from LN,
the only causative agent of HPS reported in Paraguay. According to the
results of phylogenetic analyses, this virus could probably be
considered a new lineage more related to AND virus lineages than to LN
virus (Fig. 3), suggesting that a Oligoryzomys-borne viral
variant is probably circulating. In fact, this rodent genus is known to
be circulating in Paraguay (16). Seropositive
Oligoryzomys rodents are present in the three areas in
Argentina where hantavirus is endemic (2). Moreover,
hantavirus from Bolivia (1) and Peru (24) were
associated with O. microtis. These findings show the
importance of Oligoryzomys rodents in the maintenance of
hantaviruses in South America.
The definition of hantavirus species is under discussion. In order to
assign this taxonomic status, several criteria have been taken into
account: (i) serological criterion based on cross-neutralization assays, (ii) genetic criterion based on sequence similarities, and
(iii) a geographical-ecological criterion based on maintenance and
coevolution in different primary rodent reservoirs. A direct relationship between genetic and serological data is difficult to show,
but this traditional criterion correlates remarkably well with
molecular data. Lower amino acid divergences are regularly related with
cross neutralization (15).
So far, the viruses associated to human infections in the region are
closely related to Oligoryzomys-borne viruses
(12). As shown in Fig. 3B, phylogenetic analysis based on
amino acid comparisons show a close relationship between these viruses.
Despite nucleotide sequence diversity in Oligoryzomys-borne
related virus-deduced amino acid sequences were highly conserved,
indicating a strong evolutionary pressure to maintain the sequence
integrity, suggesting a high adaptation of the virus among the
different rodents of this genus. Two lineages can be found in a rodent
species like AND Sout and AND Nort in Oligoryzomys
longicaudatus (12). On the other hand, the same viral
lineage was found in three different Oligoryzomys species
(data not shown). In our opinion, there are not yet enough reasons to
consider these different lineages as independent viruses. Species
jumping (host switching) may have occurred, and Dobrava virus has been
demonstrated in two rodent species (15, 21, 28). The
relationships within the Oligoryzomys genus are not clearly
known (17). Additional rodent phylogenetic studies and
long-term studies for the determination of rodent-virus association
should be useful in addition to cross neutralization assays in order to
clarify this issue. We suggest naming these lineages Andes and adding a
geographical reference as is usually done for hantaviruses.
A thorough analysis of new genotypes ultimately requires sequencing of
their complete genomes, but sequencing of two sufficiently large
regions such as the beginning of the G1- and G2-coding regions seems to
provide a reliable alternative to the complete genome. The conserved
N-coding region contains insufficient sequence diversity to be able to
distinguish genotypes by phylogenetic analysis. However, the G2-coding
region, extensively used for SN virus (15) may be employed
for routine genotyping, since primers used are within a region highly
conserved to allow PCR amplification even though providing
differentiation. In our geographical region, similarity analysis of
G2-encoding M-segment fragment (nt 2721 to 2946) was shown to be useful
for the identification of lineages.
The results presented here provide new information on HPS virus
variability in five countries in South America including the description of at least one new AND lineage (and probably two). Determining the variants involved in human disease can be useful in
order to improve control measures. Recently, genetic investigation has
revealed the presence of novel hantaviruses in Brazil, some of which
appear to be more closely related to the Argentinean viruses than to
each other (8).
Although this study involved an overview of hantavirus infection in
South America, many more viruses will probably be reported in the
future, and much more data will be necessary for understanding hantavirus diversity and evolution.
 |
ACKNOWLEDGMENTS |
We gratefully acknowledge the contributions of Daniel Gutson in
mathematics. We also thank Juan Carnival for helpful clinical discussions. Special thanks go to Maria Cristina Oses for technical support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departamento de
Virología, Instituto Nacional de Enfermedades Infecciosas,
A.N.L.I.S. "Dr. Carlos G. Malbrán," Av. Velez Sarsfield 563, 1281 Buenos Aires, Argentina. Phone and fax: (54-11) 4301-3146. E-mail: ppadula{at}cvtci.com.ar.
 |
REFERENCES |
| 1.
|
Bharadwaj, M.,
J. Botten,
N. Torrez-Martinez, and B. Hjelle.
1997.
Rio Mamore virus: genetic characterization of a newly recognized hantavirus of the pygmy rice rat, Oligoryzomys microtis, from Bolivia.
Am. J. Trop. Med. Hyg.
57:368-374.
|
| 2.
|
Calderon, G.,
N. C. Pini,
J. Bolpe,
S. Levis,
J. Mills,
E. L. Segura,
N. Guthmann,
G. Cantoni,
J. Becker,
A. Fonollat,
C. Ripoll,
M. Bortman,
R. Benedetti,
M. Sabattini, and D. A. Enria.
1999.
Hantavirus reservoir hosts associated with peridomestic habitants in Argentina. Emerg. Infect. Dis., vol. 5.
[Online.] http://www.cdc.gov/ncidod/EID/vol5no6/calderon.htm.
|
| 3.
|
Chiappero, M. B.,
G. E. Calderon, and C. N. Gardenal.
1997.
Oligoryzomys flavescens (Rodentia, Muridae): gene flow among populations from central-eastern Argentina.
Genetica
101:105-113[CrossRef][Medline].
|
| 4.
|
Duchin, J. S.,
F. T. Koster,
C. J. Peters,
G. L. Simpson,
B. Tempest,
S. R. Zaki,
T. G. Ksiazek,
P. E. Rollin,
S. Nichol,
E. T. Umland,
R. L. Moolenaar,
S. E. Reef,
K. B. Nolte,
M. M. Gallher,
J. C. Butler,
R. F. Breiman, and The Hantavirus Study Group.
1994.
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease.
N. Engl. J. Med.
330:949-955[Abstract/Free Full Text].
|
| 5.
|
Elliott, R. M.,
C. S. Schmaljohn, and M. S. Collet.
1991.
Bunyavirus genome structure and gene expression.
Curr. Top. Microbiol. Immunol.
169:91-141[Medline].
|
| 6.
|
Enria, D.,
P. Padula,
E. L. Segura,
N. Pini,
A. Edelstein,
C. Riva Posse, and M. C. Weissenbacher.
1996.
Hantavirus pulmonary syndrome in Argentina. Possibility of person-to-person transmission.
Medicina
56:709-711.
|
| 7.
|
Ferrer, J. F.,
C. B. Jonsson,
E. Esteban,
D. Galligan,
M. A. Basombrio,
M. Peralta-Ramos,
M. Bharadwaj,
N. Torrez-Martinez,
J. Callahan,
A. Segovia, and B. Hjelle.
1998.
High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco.
Am. J. Trop. Med. Hyg.
59:438-444[Abstract].
|
| 8.
|
Johnson, A. M.,
L. T. de Souza,
I. B. Ferreira,
L. E. Pereira,
T. G. Ksiazek,
P. E. Rolling,
C. J. Peters, and S. T. Nichol.
1999.
Genetic investigation of novel hantaviruses causing fatal HPS in Brazil.
J. Med. Virol.
59:527-535[CrossRef][Medline].
|
| 9.
|
Khan, A. S.,
T. G. Ksiazek, and C. J. Peters.
1996.
Hantavirus pulmonary syndrome.
Lancet
347:739-741[CrossRef][Medline].
|
| 10.
|
Koster, F., and H. Levy.
1999.
Clinical manifestations and treatment of HPS, p. 33-38.
In
W. H. Lee, C. Calisher, and C. Schmaljohn (ed.), Manual of hemorrhagic with renal syndrome and hantavirus pulmonary syndrome. WHO Collaborating Center for Virus Reference and Research (Hantaviruses). Asan Institute for Life Sciences, Seoul, Korea.
|
| 11.
|
Lee, J. S.
1999.
Clinical manifestations and treatment of HFRS and HPS, p. 18-27.
In
W. H. Lee, C. Calisher, and C. Schmaljohn (ed.), Manual of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. WHO Collaborating Center for Virus Reference and Research (Hantaviruses). Asan Institute for Life Sciences, Seoul, Korea.
|
| 12.
|
Levis, S.,
S. Morzunov,
J. Rowe,
D. A. Enria,
N. Pini,
G. Calderon,
M. Sabattini, and S. C. St. Jeor.
1998.
Genetic diversity and epidemiology of hantaviruses in Argentina.
J. Infect. Dis.
177:529-538[Medline].
|
| 13.
|
López, N.,
P. Padula,
C. Rossi,
M. E. Lázaro, and M. T. Franze-Fernández.
1996.
Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina.
Virology
220:223-226[CrossRef][Medline].
|
| 14.
|
López, N.,
P. Padula,
C. Rossi,
S. Miguel,
A. Edelstein,
E. Ramírez, and M. T. Franze-Fernández.
1997.
Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile.
Virus Res.
50:77-84[CrossRef][Medline].
|
| 15.
|
Monroe, M. C.,
S. P. Morzunov,
A. M. Johnson,
M. D. Bowen,
H. Artsob,
T. Yates,
C. J. Peters,
P. E. Rollin,
T. G. Ksiazek, and S. T. Nichol.
1999.
Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America.
Emerg. Infect. Dis.
5:75-86[Medline].
|
| 16.
|
Musser, G. G., and M. D. Carleton.
1993.
Family Muridae, p. 501-755.
In
D. E. Wilson, and D. M. Reeder (ed.), Mammal species of the world. Smithsonian Institution Press, Washington, D.C.
|
| 17.
|
Myers, P.,
B. Lundrigan, and P. K. Tucker.
1995.
Molecular phylogenetics of oryzomyine rodents: the genus Oligoryzomys.
Mol. Phylogenet. Evol.
4:372-382[CrossRef][Medline].
|
| 18.
|
Nichol, S. T.,
C. F. Spiropoulou,
S. Morzunov,
P. E. Rolling,
T. G. Ksiazek,
H. Feldmann,
A. Sanchez,
J. Childs,
S. Zaki, and C. J. Peters.
1993.
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness.
Science
262:914-917[Abstract/Free Full Text].
|
| 19.
|
Padula, P. J.,
A. Edelstein,
S. D. L. Miguel,
N. M. López,
C. M. Rossi, and R. D. Rabinovich.
1998.
Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus.
Virology
241:323-330[CrossRef][Medline].
|
| 20.
| Padula, P. J., C. M. Rossi, M. O. Della
Valle, V. P. Martínez, S. B. Colavecchia, A. Edelstein, S. D. L. Miguel, R. D. Rabinovich, and
E. L. Segura. Development and evaluation of a solid phase
enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein.
J. Med. Microbiol., in press.
|
| 21.
|
Peters, C. J.
1998.
Hantavirus pulmonary syndrome in the Americas.
Emerg. Infect.
2:17-64.
|
| 22.
|
Pini, N. C.,
A. Resa,
G. del J. Laime,
G. Lecot,
T. G. Kziazek,
S. Levis, and D. A. Enria.
1998.
Hantavirus infection in children in Argentina.
Emerg. Infect. Dis.
4:85-87[Medline].
|
| 23.
|
Plyusnin, A.,
O. Vapalahti, and A. Vaheri.
1996.
Hantaviruses: genome structure, expression and evolution.
J. Gen. Virol.
77:2677-2687[Abstract/Free Full Text].
|
| 24.
|
Powers, A. M.,
D. R. Mercer,
D. M. Watts,
H. Guzman,
C. F. Fulhorst,
V. L. Popov, and R. B. Tesh.
1999.
Isolation and genetic characterization of a hantavirus (Bunyaviridae: Hantavirus) from a rodent, Oligoryzomys microtis (Muridae), collected in northeastern Peru.
Am. J. Trop. Med. Hyg.
61:92-98[Abstract].
|
| 25.
|
Schmaljohn, C., and B. Hjelle.
1997.
Hantavirus: a global disease problem.
Emerg. Infect. Dis.
3:95-104[Medline].
|
| 26.
|
Terajima, M.,
J. D. Hendershot III,
H. Kariwa,
F. T. Koster,
B. Hjelle,
D. Goade,
M. C. DeFronzo, and F. A. Ennis.
1999.
High level of viremia in patients with the hantavirus pulmonary syndrome.
J. Infect. Dis.
180:2030-2034[CrossRef][Medline].
|
| 27.
|
Toro, J.,
J. D. Vega,
A. S. Khan,
J. N. Mills,
P. J. Padula,
W. Terry,
Z. Yadón,
R. Valderrama,
B. A. Ellis,
C. Pavletic,
R. Cerda,
S. Zaki,
S. Wun-Ju,
R. Meyer,
M. Tapia,
C. Mansilla,
M. Baro,
J. A. Vergara,
M. Concha,
G. Calderón,
D. Enria,
C. J. Peters, and T. G. Ksiazek.
1998.
An outbreak of hantavirus pulmonary syndrome, Chile, 1997.
Emerg. Infect. Dis.
4:687-694[Medline].
|
| 28.
|
Vapalahti, O.,
Å. Lundkvist,
V. Fedorov,
C. J. Conroy,
S. Hirvonen,
A. Plyusnina,
K. Nemirov,
K. Fredga,
J. A. Cook,
J. Niemimaa,
A. Kaikusalo,
H. Henttonen,
A. Vaheri, and A. Plyusnin.
1999.
Isolation and characterization of a hantavirus from Lemmus sibiricus: evidence for host switch during hantavirus evolution.
J. Virol.
73:5586-5592[Abstract/Free Full Text].
|
| 29.
|
Wells, R. M.,
S. Sosa Stani,
Z. E. Yadón,
E. Enria,
P. Padula,
N. Pini,
J. N. Mills,
C. J. Peters,
E. L. Segura, and The Hantavirus Pulmonary Syndrome Study Group for Patagonia.
1997.
An unusual hantavirus outbreak in southern Argentina: person-to-person transmission?
Emerg. Infect. Dis.
3:171-174[Medline].
|
| 30.
|
Williams, R. J.,
R. T. Bryan,
J. N. Mills,
R. E. Palma,
I. Vera,
F. Velasquez,
E. M. Baez,
W. E. Schmidt,
R. E. Figueroa,
C. J. Peters,
S. R. Zaki,
A. S. Khan, and T. G. Ksiazek.
1997.
An outbreak of hantavirus pulmonary syndrome in western Paraguay.
Am. J. Trop. Med. Hyg.
57:274-282.
|
Journal of Clinical Microbiology, August 2000, p. 3029-3035, Vol. 38, No. 8
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Armien, A. G., Armien, B., Koster, F., Pascale, J. M., Avila, M., Gonzalez, P., de la Cruz, M., Zaldivar, Y., Mendoza, Y., Gracia, F., Hjelle, B., Lee, S.-J., Yates, T. L., Salazar-Bravo, J.
(2009). Hantavirus Infection and Habitat Associations among Rodent Populations in Agroecosystems of Panama: Implications for Human Disease Risk. Am J Trop Med Hyg
81: 59-66
[Abstract]
[Full Text]
-
Godoy, P., Marsac, D., Stefas, E., Ferrer, P., Tischler, N. D., Pino, K., Ramdohr, P., Vial, P., Valenzuela, P. D. T., Ferres, M., Veas, F., Lopez-Lastra, M.
(2009). Andes Virus Antigens Are Shed in Urine of Patients with Acute Hantavirus Cardiopulmonary Syndrome. J. Virol.
83: 5046-5055
[Abstract]
[Full Text]
-
Medina, R. A., Torres-Perez, F., Galeno, H., Navarrete, M., Vial, P. A., Palma, R. E., Ferres, M., Cook, J. A., Hjelle, B.
(2009). Ecology, Genetic Diversity, and Phylogeographic Structure of Andes Virus in Humans and Rodents in Chile. J. Virol.
83: 2446-2459
[Abstract]
[Full Text]
-
Villafane, I. E. G., Minarro, F. O., Valenzuela, L., Bilenca, D. N.
(2009). Experimental assessment of rodent control on two poultry farms of central Argentina. J. Appl. Poult. Res.
18: 622-629
[Abstract]
[Full Text]
-
Eyzaguirre, E. J., Milazzo, M. L., Koster, F. T., Fulhorst, C. F.
(2008). Choclo Virus Infection in the Syrian Golden Hamster. Am J Trop Med Hyg
78: 669-674
[Abstract]
[Full Text]
-
Petraityte, R., Jin, L., Hunjan, R., Razanskiene, A., Zvirbliene, A., Sasnauskas, K.
(2007). Use of Saccharomyces cerevisiae-Expressed Recombinant Nucleocapsid Protein To Detect Hantaan Virus-Specific Immunoglobulin G (IgG) and IgM in Oral Fluid. CVI
14: 1603-1608
[Abstract]
[Full Text]
-
Webster, D., Lee, B., Joffe, A., Sligl, W., Dick, D., Grolla, A., Feldmann, H., Yacoub, W., Grimsrud, K., Safronetz, D., Lindsay, R.
(2007). Cluster of Cases of Hantavirus Pulmonary Syndrome in Alberta, Canada. Am J Trop Med Hyg
77: 914-918
[Abstract]
[Full Text]
-
CHU, Y. K., MILLIGAN, B., OWEN, R. D., GOODIN, D. G., JONSSON, C. B.
(2006). PHYLOGENETIC AND GEOGRAPHICAL RELATIONSHIPS OF HANTAVIRUS STRAINS IN EASTERN AND WESTERN PARAGUAY. Am J Trop Med Hyg
75: 1127-1134
[Abstract]
[Full Text]
-
RABONI, S. M., RUBIO, G., DE BORBA, L., ZEFERINO, A., SKRABA, I., GOLDENBERG, S., DOS SANTOS, C. N. D.
(2005). CLINICAL SURVEY OF HANTAVIRUS IN SOUTHERN BRAZIL AND THE DEVELOPMENT OF SPECIFIC MOLECULAR DIAGNOSIS TOOLS. Am J Trop Med Hyg
72: 800-804
[Abstract]
[Full Text]
-
Padula, P., Figueroa, R., Navarrete, M., Pizarro, E., Cadiz, R., Bellomo, C., Jofre, C., Zaror, L., Rodriguez, E., Murua, R.
(2004). Transmission Study of Andes Hantavirus Infection in Wild Sigmodontine Rodents. J. Virol.
78: 11972-11979
[Abstract]
[Full Text]
-
TORRES-PEREZ, F., NAVARRETE-DROGUETT, J., ALDUNATE, R., YATES, T. L., MERTZ, G. J., VIAL, P. A., FERRES, M., MARQUET, P. A., PALMA, R. E.
(2004). PERIDOMESTIC SMALL MAMMALS ASSOCIATED WITH CONFIRMED CASES OF HUMAN HANTAVIRUS DISEASE IN SOUTHCENTRAL CHILE. Am J Trop Med Hyg
70: 305-309
[Abstract]
[Full Text]
-
Padula, P. J., Sanchez, A. J., Edelstein, A., Nichol, S. T.
(2002). Complete nucleotide sequence of the M RNA segment of Andes virus and analysis of the variability of the termini of the virus S, M and L RNA segments. J. Gen. Virol.
83: 2117-2122
[Abstract]
[Full Text]
-
Bohlman, M. C., Morzunov, S. P., Meissner, J., Taylor, M. B., Ishibashi, K., Rowe, J., Levis, S., Enria, D., St. Jeor, S. C.
(2002). Analysis of Hantavirus Genetic Diversity in Argentina: S Segment-Derived Phylogeny. J. Virol.
76: 3765-3773
[Abstract]
[Full Text]